标题
Genetic variations in multiple myeloma II: association with effect of treatment
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 88, Issue 2, Pages 93-117
出版商
Wiley
发表日期
2011-09-01
DOI
10.1111/j.1600-0609.2011.01696.x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib
- (2011) Annette J. Vangsted et al. ANNALS OF HEMATOLOGY
- A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling
- (2011) Maria T. Di Martino et al. BRITISH JOURNAL OF HAEMATOLOGY
- Polymorphisms of nuclear factor- B family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens
- (2011) J. Du et al. HAEMATOLOGICA
- Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
- (2011) David C. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
- (2011) Philippe Moreau et al. LANCET ONCOLOGY
- Genetic variation associated with bortezomib-induced peripheral neuropathy
- (2011) Reyna Favis et al. Pharmacogenetics and Genomics
- The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP
- (2010) Annette J. Vangsted et al. ANNALS OF HEMATOLOGY
- Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin
- (2010) Gabriele Buda et al. ANNALS OF HEMATOLOGY
- No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
- (2010) Annette J Vangsted et al. BMC CANCER
- Intracellular Signals of T Cell Costimulation
- (2010) Jianxun Song et al. Cellular & Molecular Immunology
- Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994-2004*
- (2010) Annette J. Vangsted et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
- (2010) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
- (2010) Annemiek Broyl et al. LANCET ONCOLOGY
- Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone
- (2010) Juan Du et al. LEUKEMIA RESEARCH
- MDR1 C3435T Polymorphism Indicates a Different Outcome in Advanced Multiple Myeloma
- (2009) Gabriele Buda et al. ACTA HAEMATOLOGICA
- Association of a single nucleotide polymorphic variation in the human chromosome 19q13.3 with drug responses in the NCI60 cell lines
- (2009) Kari K. Nissen et al. ANTI-CANCER DRUGS
- Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study
- (2009) A. Palumbo et al. BLOOD
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
- (2009) C Dumontet et al. BONE MARROW TRANSPLANTATION
- A polymorphism in NFKB1 is associated with improved effect of interferon- maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support
- (2009) A. J. Vangsted et al. HAEMATOLOGICA
- Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
- (2009) Cristina Rodriguez-Antona et al. HUMAN GENETICS
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- ABCB1 (MDR1)rs1045642 is associated with increased overall survival in plasma cell myeloma
- (2009) Stephen Drain et al. LEUKEMIA & LYMPHOMA
- Enforced expression ofPPP1R13Lincreases tumorigenesis and invasion through p53-dependent and p53-independent mechanisms
- (2009) Magdalena J. Laska et al. MOLECULAR CARCINOGENESIS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Bisphosphonate-related osteonecrosis: genetic and acquired risk factors
- (2009) ME Sarasquete et al. ORAL DISEASES
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- First thalidomide clinical trial in multiple myeloma: a decade
- (2008) F. van Rhee et al. BLOOD
- Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis
- (2008) M. E. Sarasquete et al. BLOOD
- Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
- (2008) D. C. Johnson et al. BLOOD
- Dysfunctional homologous recombination mediates genomic instability and progression in myeloma
- (2008) M. A. Shammas et al. BLOOD
- The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
- (2008) A J Vangsted et al. BONE MARROW TRANSPLANTATION
- Clinical Pharmacogenetics and Potential Application in Personalized Medicine
- (2008) Shu-Feng Zhou et al. CURRENT DRUG METABOLISM
- Treatment of newly diagnosed myeloma
- (2008) A Palumbo et al. LEUKEMIA
- Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: Implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms
- (2008) Ingolf Mølle et al. LEUKEMIA & LYMPHOMA
- MDR1 diplotypes as prognostic markers in multiple myeloma
- (2008) Valentina Maggini et al. Pharmacogenetics and Genomics
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
- Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms
- (2007) Valentina Maggini et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now